Superluminal Medicines vs Doximity

Side-by-side comparison of AI visibility scores, market position, and capabilities

Doximity leads in AI visibility (86 vs 75)
Superluminal Medicines logo

Superluminal Medicines

LeaderHealthcare

General

Boston AI GPCR drug discovery with $1.3B Eli Lilly collaboration Aug 2025 for obesity/cardiometabolic; $158M total ($120M RA Capital/Insight/NVIDIA/Lilly Series A Sep 2024) with MC4R obesity program advancing to IND competing with Relay Therapeutics.

AI VisibilityBeta
Overall Score
B75
Category Rank
#79 of 596
AI Consensus
72%
Trend
stable
Per Platform
ChatGPT
76
Perplexity
80
Gemini
69

About

Superluminal Medicines is a Boston-based biotechnology company — backed with approximately $158 million in total funding including a $33 million seed in 2023 and a $120 million Series A in September 2024 led by RA Capital Management with Insight Partners, NVIDIA's NVentures, and Eli Lilly — developing AI-driven small molecule drugs targeting G protein-coupled receptors (GPCRs), combining artificial intelligence, protein dynamics simulation, and structural biology to discover drugs for 70% of GPCRs that currently remain "undruggable" despite GPCRs representing the target class for approximately 35% of all FDA-approved drugs. In August 2025, Superluminal secured a landmark $1.3 billion collaboration agreement with Eli Lilly to discover small molecule therapeutics for obesity and cardiometabolic diseases, and is advancing its lead internal MC4R agonist program (for obesity treatment) toward IND-enabling studies with human trials expected Q4 2026. Founded in 2022.

Full profile
Doximity logo

Doximity

GrowthHealthTech

Physician Professional Network

Doximity (NYSE: DOCS), professional network for US physicians with 2M+ verified clinicians; telehealth, medical news, and career tools monetized via pharmaceutical digital marketing.

AI VisibilityBeta
Overall Score
A86
Category Rank
#6 of 596
AI Consensus
85%
Trend
stable
Per Platform
ChatGPT
85
Perplexity
84
Gemini
88

About

Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinicians on the platform — representing the majority of practicing US physicians — Doximity has established itself as the dominant professional network for doctors, providing identity-verified peer connections, specialty-specific news feeds, medical journal access, and career management tools including a physician job board and CV builder. The verification layer distinguishes Doximity from general professional networks and makes it the standard reference for confirming physician credentials and contact information across the healthcare industry.

Full profile

AI Visibility Head-to-Head

75
Overall Score
86
#79
Category Rank
#6
72
AI Consensus
85
stable
Trend
stable
76
ChatGPT
85
80
Perplexity
84
69
Gemini
88
70
Claude
81
76
Grok
85

Key Details

Category
General
Physician Professional Network
Tier
Leader
Growth
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Doximity
Physician Professional Network

Integrations

Only Superluminal Medicines

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.